IDEXX Laboratories Inc. (IDXX)
Health Care3 articles
Price chart
Why is IDXX moving today?
+2.4%IDXX is +2.4% today, inside the ordinary range for a session (under 3%). No stories about it reached the feed in the last 24 hours.
What this does not prove. A story on the same day is evidence of timing, not of cause: it explains a move only if it accounts for the size and the direction, and most single-stock moves carry a sector or index component too. Nothing here is a forecast.
Source: Yahoo Finance - quote as of 2 days ago
IDEXX Laboratories Inc. (IDXX) overview
IDEXX Laboratories provides veterinary diagnostics and software.
IDXX is a member of the S&P 500. It sits in the Health Care sector. That sector covers pharmaceutical, biotech, device and managed-care companies.
IDEXX Laboratories Inc. trades on the NasdaqGS under the ticker symbol IDXX. The most recent market data puts the share price at about $560.36. That is up 2.41% on the session. At that price the company is worth roughly $44.15B.
Over the past 52 weeks, IDXX has traded between $500.61 and $769.98. Shares change hands at a trailing price-to-earnings (P/E) ratio of about 39.4. The P/E ratio sets the share price against a year of earnings. A higher number means the market is paying more for each dollar the company earns.
Key statistics
Source: Yahoo Finance - quote as of 2 days ago
Informational only, not financial advice. Content is AI-generated and may contain errors. How this works.
Why investors watch IDXX
IDXX is one of the larger names in the Health Care sector, so investors follow it closely. It tends to move with the rest of the sector. This page sums up each IDXX story as it breaks, and tags it bullish, bearish or neutral.
What moves IDXX
- Earnings. IDXX reports results four times a year. A surprise against the estimate tends to move the stock that day.
- Analyst calls. Upgrades, downgrades and new price targets change what the market expects from IDXX.
- Sector news. Health Care stocks often move together, so a rival's news can move IDXX too.
Market Mood
Latest IDXX news
IDEXX (IDXX) Growth Plan Highlights Innovation at Morgan Stanley
IDEXX Laboratories (IDXX) presented its growth strategy focused on innovation at the recent Morgan Stanley conference. The company aims to enhance its product offerings and leverage new technologies to drive future growth. While specific financial targets were not disclosed, the emphasis on innovation reflects IDEXX's commitment to maintaining competitive advantages in the veterinary diagnostics market. This growth approach may influence investor confidence and market positioning for IDEXX.
Read More: IDEXX (IDXX) Growth Plan Highlights Innovation at Morgan Stanley
Baron Fund Reports IDEXX Laboratories (IDXX) Holdings and Performance
In Q2 2026, Baron Focused Growth Fund achieved a 13.26% gain, compared to a 24.02% return for the Russell 2500 Growth Index. IDEXX Laboratories, Inc. (NASDAQ: IDXX), a key holding, closed at $562.20 per share on August 19, 2026, with a market capitalization of $44.29 billion. IDEXX reported a one-month return of 4.23%, but its shares declined by 11.19% over the past 52 weeks. This information highlights the Fund's investment strategy focusing on industry leaders like IDEXX, demonstrating potential market resilience which may interest investors looking for growth in the healthcare sector.
Read More: Baron Fund Reports IDEXX Laboratories (IDXX) Holdings and Performance
IDEXX Laboratories Stock Evaluation: Insights for Potential Investors
IDEXX Laboratories, Inc. (IDXX) is currently facing scrutiny regarding its stock performance amid changing market conditions. Investors are evaluating recent financial results and growth potential, which could influence future price movement. Analysts suggest that while the company's fundamentals remain strong, market volatility and sector performance could significantly impact investment decisions. Monitoring key indicators such as earnings reports and market trends will be crucial for investors considering entry points.
Read More: IDEXX Laboratories Stock Evaluation: Insights for Potential InvestorsMore Health Care stocks
Frequently asked questions
Is IDEXX Laboratories Inc. in the S&P 500?
Yes. IDEXX Laboratories Inc. trades as IDXX and is a member of the S&P 500. The index lists it in the Health Care sector.
What sector is IDXX in?
IDXX sits in the Health Care sector of the S&P 500.
Where can I find the latest IDXX news?
Right here. This page collects recent IDXX news and market analysis. Every story gets an AI summary and a bullish, bearish or neutral tag.
What is IDEXX Laboratories Inc.'s stock price?
IDXX last traded at about $560.36. Prices move all through the session, so this is the latest quote rather than a live one.
What is IDEXX Laboratories Inc.'s market cap?
IDXX is worth roughly $44.15B. Market cap is the share price times the number of shares outstanding.
What is IDXX's P/E ratio?
IDXX trades at a trailing P/E ratio of about 39.4. The ratio compares the share price with earnings per share over the past year.